These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12851802)

  • 1. Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin.
    Gheno G; Cinetto L; Savarino C; Vellar S; Carraro M; Randon M
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):373-7. PubMed ID: 12851802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study.
    Koren-Michowitz M; Avni B; Michowitz Y; Moravski G; Efrati S; Golik A
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):299-302. PubMed ID: 15133781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prophylactic treatment with low-molecular-weight heparin bemiparin sodium on serum potassium levels: a prospective observational study.
    Torres OH; Hernandez N; Francia E; Barcelo M; Mateo J; Ruiz D
    Drugs Aging; 2010 May; 27(5):399-406. PubMed ID: 20450237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
    Alappan R; Buller GK; Perazella MA
    Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperkalemia due to low-molecular-weight heparin].
    van der Heiden W; Koopman JJEB; Appelman-Dijkstra NM; den Exter PL
    Ned Tijdschr Geneeskd; 2022 Jun; 166():. PubMed ID: 35736382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperkalemia secondary to concurrent pharmacotherapy in a patient receiving home parenteral nutrition.
    Brown RO; Hamrick KD; Dickerson RN; Lee N; Parnell DH; Kudsk KA
    JPEN J Parenter Enteral Nutr; 1996; 20(6):429-32. PubMed ID: 8950745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial.
    Melzer N; Bramlage P; Michaelis HC
    BMC Res Notes; 2014 Dec; 7():880. PubMed ID: 25480344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of switching unfractionated heparin to low-molecular-weight heparin on serum potassium in hemodialysis patients.
    Ezzatzadegan Jahromi S; Mahmoodi MS; Behroozi F; Roozbeh J; Emamghoreishi F
    Iran J Kidney Dis; 2014 Nov; 8(6):475-80. PubMed ID: 25362223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-molecular-weight heparin on serum concentrations of potassium.
    Wiggam MI; Beringer TR
    Lancet; 1997 Jul; 350(9073):292-3. PubMed ID: 9242823
    [No Abstract]   [Full Text] [Related]  

  • 11. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
    Weir MR; Bakris GL; Bushinsky DA; Mayo MR; Garza D; Stasiv Y; Wittes J; Christ-Schmidt H; Berman L; Pitt B;
    N Engl J Med; 2015 Jan; 372(3):211-21. PubMed ID: 25415805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-therapeutic anti-Xa levels in medical patients receiving anticoagulant therapy with enoxaparin.
    Ramos-Esquivel A; Salazar-Sánchez L
    Thromb Res; 2013 Oct; 132(4):433-6. PubMed ID: 24050826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
    Bakris GL; Pitt B; Weir MR; Freeman MW; Mayo MR; Garza D; Stasiv Y; Zawadzki R; Berman L; Bushinsky DA;
    JAMA; 2015 Jul; 314(2):151-61. PubMed ID: 26172895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
    Alappan R; Perazella MA; Buller GK
    Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.
    Hammerstingl C; Omran H; Tripp C; Poetzsch B
    Thromb Haemost; 2009 Feb; 101(2):325-32. PubMed ID: 19190817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP;
    Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N; Kalaitzidis R; Bakris GL
    Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium zirconium cyclosilicate in hyperkalemia.
    Packham DK; Rasmussen HS; Lavin PT; El-Shahawy MA; Roger SD; Block G; Qunibi W; Pergola P; Singh B
    N Engl J Med; 2015 Jan; 372(3):222-31. PubMed ID: 25415807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.